Celyad SA Sponsored ADR
(NASDAQ : CYAD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
1.79%17.662.0%$111.93m
SAGESAGE Therapeutics, Inc.
1.80%160.939.5%$82.08m
JAZZJazz Pharmaceuticals Plc
0.49%125.932.2%$74.89m
ICPTIntercept Pharmaceuticals, Inc.
-0.34%110.8218.6%$68.57m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.53%150.496.3%$65.14m
PRGOPerrigo Co. Plc
0.76%48.976.8%$61.26m
PTLAPortola Pharmaceuticals, Inc.
3.86%30.967.7%$42.74m
CTLTCatalent Inc
1.06%42.022.4%$41.89m
ICLRICON Plc
0.67%145.054.1%$35.72m
UTHRUnited Therapeutics Corporation
0.92%119.6314.4%$31.22m
HZNPHorizon Pharma plc
1.05%23.177.4%$30.97m
CORTCorcept Therapeutics Incorporated.
3.69%11.805.5%$28.89m
AERIAerie Pharmaceuticals, Inc.
1.66%41.756.9%$28.04m
IRWDIronwood Pharmaceuticals, Inc. Class A
9.20%15.2010.1%$27.87m
MDCOMedicines Company
3.17%24.7721.8%$27.83m

Company Profile

Celyad SA is a clinical-stage biopharmaceutical company, which engages in the identification and development of specialized cell-based therapies. Its products include cardiopoiesis platform, immuno-oncology, and medical devices. The company was founded by Michel Lussier and William Wijns on July 24, 2007 and is headquartered in Mont-Saint-Guibert, Belgium.